Identification of a novel point mutation in platelet glycoprotein Ibα, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease
- 1 October 2003
- journal article
- case report
- Published by Wiley in Journal of Thrombosis and Haemostasis
- Vol. 1 (10) , 2198-2205
- https://doi.org/10.1046/j.1538-7836.2003.00369.x
Abstract
Summary. Background: Interaction between platelet glycoprotein (GP)Ibα and von Willebrand factor (VWF) has critical roles in both physiological hemostasis and thrombosis. Platelet‐type von Willebrand disease (plt‐VWD) is a congenital bleeding disorder characterized by gain‐of‐function mutations of GPIbα. To date, two mutations in GPIbα, G233V and M239V, have been reported in four unrelated families with plt‐VWD. Objective: The present study aimed to determine whether G233S of GPIbα, a new mutation observed in plt‐VWD patients, causes the plt‐VWD phenotype and to examine whether conversions to other residues at this position affect VWF binding. Patients and methods: The propositus was a 3‐year‐old Japanese male. He displayed bleeding symptoms and moderate thrombocytopenia. His brother was similarly affected. Platelets from both patients were analyzed by ristocetin‐ or shear‐induced platelet aggregation. DNA sequencing was performed to analyze the GPIbα sequence. We examined the 125I‐labeled VWF binding using a series of recombinant GPIbα fragments with different residues at position 233 (G233S, G233A, G233K, and G233D) together with naturally occurring mutations previously reported in patients (G233V and M239V). Results: Platelet function analysis indicated that platelets from both patients had a typical plt‐VWD phenotype. DNA sequencing analysis showed a heterozygous mutation of Gly to Ser at residue 233 of GPIbα in both patients. The 125I‐labeled VWF binding to mutant compared with the wild type displayed three patterns, gain‐of‐function (G233S, G233V, and M239V), equivalent function (G233A), and loss‐of‐function (G233K and G233D). Conclusions: The G233S is a molecular basis of plt‐VWD, and residue 233 plays critical roles in regulating VWF binding.Keywords
This publication has 32 references indexed in Scilit:
- Crystal Structure of the Platelet Glycoprotein Ibα N-terminal Domain Reveals an Unmasking Mechanism for Receptor ActivationJournal of Biological Chemistry, 2002
- Tyrosine Sulfation of Glycoprotein IbαJournal of Biological Chemistry, 2001
- De novo mutation of the platelet glycoprotein Ib?? gene in a patient with pseudo-von Willebrand diseaseBlood Coagulation & Fibrinolysis, 1997
- High Shear Stress Attenuates Agonist-Induced, Glycoprotein IIb/IIIa-Mediated Platelet Aggregation When von Willebrand Factor Binding to Glycoprotein Ib/IX Is BlockedBiochemical and Biophysical Research Communications, 1997
- Structural implications of the substitution of Val for met at residue 239 in the alpha chain of human platelet glycoprotein IBProtein Journal, 1994
- Point mutation in a leucine-rich repeat of platelet glycoprotein Ib alpha resulting in the Bernard-Soulier syndrome.Journal of Clinical Investigation, 1993
- Low shear stress can initiate von Willebrand factor-dependent platelet aggregation in patients with type IIB and platelet-type von Willebrand disease.Journal of Clinical Investigation, 1993
- Conformational energy analysis of the substitution of Val for Gly 233 in a functional region of platelet GPIbα in platelet-type von Willebrand diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991
- Structure of the human blood platelet membrane glycoprotein Ibα geneBiochemical and Biophysical Research Communications, 1988
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978